TickerFactsScreenerDevelopers

Theriva Biologics, Inc. (TOVX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $6.68M2012: $9.95M2013: $14.62M2014: $17.52M2015: $20.82M2016: $19.05M2017: $17.12M2018: $28.92M2019: $15.04M2020: $6.23M2021: $67.33M2022: $41.79M2023: $23.18M2024: $11.61M2025: $13.06M$13.06M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$13.06M+12.5%
2024$11.61M-49.9%
2023$23.18M-44.5%
2022$41.79M-37.9%
2021$67.33M+981.2%
2020$6.23M-58.6%
2019$15.04M-48.0%
2018$28.92M+69.0%
2017$17.12M-10.2%
2016$19.05M-8.5%
2015$20.82M+18.8%
2014$17.52M+19.8%
2013$14.62M+46.9%
2012$9.95M+49.1%
2011$6.68M—